瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01501 瑛泰医疗

交易中 09-08 11:25:49

32.100

-0.960

-2.90%

最高33.460	最低32.000	成交量7.22万
今开32.920	昨收33.060	日振幅4.42%
总市值67.73亿	流通市值67.73亿	总股本2.11亿
成交额237.37万	换手率0.03%	流通股本2.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01501","market":"HK","secType":"STK","nameCN":"瑛泰医疗","latestPrice":32.1,"timestamp":1788837781278,"preClose":33.06,"halted":0,"volume":72200,"delay":0,"changeRate":-0.02903811252268605,"floatShares":211000000,"shares":211000000,"eps":1.26,"marketStatus":"交易中","change":-0.96,"latestTime":"09-08 11:25:49","open":32.92,"high":33.46,"low":32,"amount":2373654,"amplitude":0.044162,"askPrice":32.58,"askSize":1400,"bidPrice":32.1,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":1.257,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1788840000000},"marketStatusCode":2,"adr":0,"listingDate":1573142400000,"exchange":"SEHK","adjPreClose":33.06,"dividendRate":0.008361,"openAndCloseTimeList":[[1788831000000,1788840000000],[1788843600000,1788854400000]],"volumeRatio":0.616214,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603987","market":"SH","secType":"STK","nameCN":"康德莱","latestPrice":7.63,"timestamp":1788837944000,"preClose":7.58,"halted":0,"volume":1351200,"delay":0,"premium":"+260.04"}},"requestUrl":"/m/hq/s/01501","defaultTab":"news","newsList":[{"id":"1119957422","title":"瑛泰医疗2026年8月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1119957422","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119957422?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:01","pubTimestamp":1788339705,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司于2026年9月2日发布2026年8月股份变动月报表，披露自2026年8月1日至2026年8月31日的股份变动及股本结构等情况。公告显示，公司于本月无新增发行或库藏股变动。截至2026年8月31日，普通股（H股）股本月末结余数为211,200,000股，较上月底维持不变，面值为每股人民币1元，注册资本总额仍为人民币211,200,000元。本次公告由公司董事会主席兼执行董事梁栋科签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271669","title":"瑛泰医疗(01501)：王瑞琴辞任公司非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271669","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661271669?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:18","pubTimestamp":1787577529,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗 发布公告，王瑞琴先生因个人工作安排调整，已提呈辞任公司非执行董事，自2026年8月24日起生效。蹇锡高先生及许鸿群先生自2018年12月8日起担任公司独立非执行董事，至今连续任职已超过七年。蹇锡高先生及许鸿群先生的辞任将自新任独立非执行董事正式就任之日起生效。建议委任独立非执行董事尚须待股东于临时股东会上以普通决议案方式批准后，方可作实，并将自临时股东会批准之日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188325882","title":"瑛泰医疗（01501）多项董事会人事及治理结构调整　拟向董事长授出最多521万股H股奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1188325882","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188325882?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577344,"startTime":"0","endTime":"0","summary":"2026年8月24日，上海瑛泰医疗器械股份有限公司发布多项董事会及公司治理相关公告，主要内容如下：。非执行董事王瑞琴先生因个人工作安排调整，已向公司提出辞任非执行董事，自2026年8月24日起生效。其辞任自新任独立非执行董事就任之日起生效。董事会建议委任张鹏博士（59岁）及黎云龙博士（58岁）为第四届董事会独立非执行董事候选人，任期自临时股东会批准之日起至本届董事会届满。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140403589","title":"瑛泰医疗（01501）公布最新董事会及三大专门委员会成员名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1140403589","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140403589?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577341,"startTime":"0","endTime":"0","summary":"公告中未披露其他财务数据。公司强调，本次披露为例行性信息更新，旨在让投资者及时掌握公司董事会及专门委员会的人员安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168381491","title":"瑛泰医疗（01501）发布2026年中期业绩：营收5.96亿元 同比增29% 毛利率升至61.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168381491","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168381491?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577339,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司8月24日披露截至2026年6月30日止六个月未经审核中期业绩。期内，公司实现收入5.9606亿元，同比增长29.28%；归属于公司股东的净利润1.2567亿元，同比增长22.68%。报告期内，公司毛利3.6438亿元，同比增加34.63%；毛利率由58.70%升至61.13%。公司解释，毛利率提升主要源于收购并购完善产品品类矩阵，以及毛利率相对较低的代理业务收入占比下降。成本及费用方面，销售成本2.3168亿元，同比增加21.67%。期内所得税费用1,901.4万元，实际所得税率13.14%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661527130","title":"瑛泰医疗(01501)发布中期业绩，股东应占利润1.1亿元 同比增加11.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661527130","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661527130?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗(01501)发布截至2026年6月30日止6个月中期业绩，该集团取得收入5.96亿元，同比增加29.28%;公司权益股东应占利润1.1亿元，同比增加11.97%;每股盈利0.54元。公告称，收入增加主要是由于收购及并购填补了产品缺口，构建了完整的产品品类矩阵;以及透过渠道复用及供应链整合实现协同效应，从而推动介入医疗器械销量增长所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗(01501)发布中期业绩，股东应占利润1.1亿元 同比增加11.97%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108635189","title":"瑛泰医疗（01501）定于8月24日审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1108635189","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108635189?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524355,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司（01501）8月12日公告，公司董事会将于2026年8月24日（星期一）召开会议，主要议程包括：一是审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审核中期业绩，以供发布；二是考虑宣派中期股息（如有）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172420791","title":"瑛泰医疗（01501）宣布2026年8月25日至9月24日暂停股份过户 9月24日举行第一次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1172420791","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172420791?lang=zh_cn&edition=full","pubTime":"2026-08-10 17:05","pubTimestamp":1786352733,"startTime":"0","endTime":"0","summary":"2026年8月10日，瑛泰医疗发布公告称，公司董事会决定于2026年9月24日（星期四）召开2026年第一次临时股东大会。为厘定股东出席会议并行使表决权的资格，公司将自2026年8月25日（星期二）至2026年9月24日（星期四）暂停办理股份过户登记。截至公告日，瑛泰医疗董事会成员包括：执行董事梁栋科博士、林森先生；非执行董事宋媛博士、王瑞琴先生、陈红琴女士及张泓先生；独立非执行董事蹇锡高先生、许鸿群先生及徐从礼先生。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154237075","title":"瑛泰医疗7月股份变动月报：股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1154237075","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154237075?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:01","pubTimestamp":1785834111,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司于2026年8月4日发布2026年7月股份变动月报，报告期为2026年7月1日至7月31日。公告显示，公司于报告期未新增发行股份或进行股份回购。公告中透露，截至7月末，瑛泰医疗普通股的公众持股比例符合香港联合交易所有限公司的最低公众持股量要求。据悉，该公告由公司董事长兼执行董事梁栋科签署。报告期内，瑛泰医疗股本结构总体保持稳定，未来将继续依照监管规定履行信息披露义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194967831","title":"瑛泰医疗：Central Huijin Investment Ltd.增持，好仓比例升至9.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194967831","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194967831?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:12","pubTimestamp":1785489131,"startTime":"0","endTime":"0","summary":"Central Huijin Investment Ltd.于2026年7月29日以每股均价33.1857港元买入瑛泰医疗9,800股，涉资约32.52万港元。Central Huijin Investment Ltd.此次增持前持有瑛泰医疗好仓1900.30万股，占比8.99%；增持后持股量为1901.28万股，好仓比例升至9.0%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654203941","title":"港股瑛泰医疗“回A”辅导期卷入杭州“准独角兽”股权纠纷 德诺电生理股东会两议案遭投资方股东四大质疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2654203941","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654203941?lang=zh_cn&edition=full","pubTime":"2026-07-25 01:29","pubTimestamp":1784914198,"startTime":"0","endTime":"0","summary":"三个月前，一家“德诺系”公司——“准独角兽”杭州德诺电生理医疗科技有限公司（以下简称德诺电生理）被投资方股东曝出存在“反稀释权和优先清算权”的股东权利纠纷。彼时，前新财富医药“一姐”张明芳控诉德诺电生理一直无法提供附带25个股东签署盖章才能生效的《特殊股东权利终止协议》（以下简称终止协议）书面原件和扫描件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607253820874454.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607253820874454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01501","VXUS","BK4588","BK4585","BK1222","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653040729","title":"瑛泰医疗(01501.HK)间接收购上海袤熠100%合伙权益 总对价约3.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653040729","media":"中金财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653040729?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:57","pubTimestamp":1784818623,"startTime":"0","endTime":"0","summary":"格隆汇7月23日丨瑛泰医疗公告，于2026年7月23日，公司及其指定全资子公司与上海袤熠若干现有合伙人订立合伙权益转让协议，据此，转让人已同意转让，而受让人已同意境内间接收购上海袤熠100%合伙权益，总对价约人民币3.74亿元。上海袤熠间接持有目标公司Valgen Holding Corporation579,866股B轮优先股，占目标公司Valgen Holding Corporation已发行股本总额约3.85%。　　目标公司为Valgen Holding Corporation，乃一家根据开曼群岛法律注册成立并存续的获豁免公司，其持有德晋医疗100%股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260723/32316346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191344696","title":"瑛泰医疗（01501）55,120,192美元再购合伙权益 间接持股Valgen达27.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191344696","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191344696?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:25","pubTimestamp":1784816737,"startTime":"0","endTime":"0","summary":"2026年7月23日晚，瑛泰医疗器械股份有限公司公告称，已与旗下指定全资子公司及上海袤熠企业管理咨询合伙企业现有三名合伙人签署《合伙权益转让协议》，以5,5120.192万美元收购上海袤熠100%合伙权益。上述对价对应相关B轮优先股每股价格约为95.057美元。\\n\\n交易完成后，瑛泰医疗将直接及通过上海袤熠、Max Grand Limited间接合计持有目标公司4,193,775股股份，占目标公司已发行股本约27.82%。至2025年12月31日，目标公司未审计资产总值为6.92亿元，未审计净负债约5.22亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653726278","title":"瑛泰医疗(01501.HK)拟斥资约5512.02万美元进一步收购德晋医疗股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2653726278","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653726278?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:23","pubTimestamp":1784816586,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143242081","title":"瑛泰医疗6月股份变动月报：H股增至2.11亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143242081","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143242081?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:11","pubTimestamp":1782983498,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司于2026年7月2日披露截至2026年6月30日止的股份变动月报，公告显示公司本月完成内资股转H股操作，H股数量大幅上升。本次报告期内，瑛泰医疗已发行H股由上月底的139,413,392股增加至211,200,000股，增加数量为71,786,608股；与此同时，内资股从71,786,608股降至0股，显示全部内资股均于2026年6月3日转换为H股。本次月报由公司主席兼执行董事梁栋科签署。公司强调将持续满足香港联交所对于股份发行、买卖和信息披露的合规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647887303","title":"瑛泰医疗(01501.HK)根据H股奖励信托计划授出3.34万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2647887303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647887303?lang=zh_cn&edition=full","pubTime":"2026-06-29 23:15","pubTimestamp":1782746123,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647832004","title":"康德莱：瑛泰医疗的价值放大，有益于所有持有其股份的投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2647832004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647832004?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:54","pubTimestamp":1782726847,"startTime":"0","endTime":"0","summary":"证券之星消息，康德莱06月29日在投资者关系平台上答复投资者关心的问题。你公司持有瑛泰医疗股份。瑛泰医疗的价值放大，有益于所有持有其股份的投资者。关于中报业绩情况，公司将严格按照交易所要求履行信息披露义务，请您关注公司后续公告。股价波动受多重因素影响，公司经营正常有序。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","BK0251","603987","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801312","title":"瑛泰医疗(01501)拟斥资1000万美元进一步收购德晋医疗约0.79%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801312","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646801312?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:54","pubTimestamp":1782399279,"startTime":"0","endTime":"0","summary":"据悉，目标公司持有德晋医疗100%股权。其中，DragonFly经导管二尖瓣夹系统为国家药监局批准的首款国产经导管二尖瓣产品。于首次收购事项及第二次收购事项均完成后，公司将合共持有目标公司已发行股本总额约23.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114269978","title":"瑛泰医疗（01501）再投1,000万美元增持Valgen 0.79%股权，持股升至23.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114269978","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114269978?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:52","pubTimestamp":1782399143,"startTime":"0","endTime":"0","summary":"6月25日，上海瑛泰医疗器械股份有限公司公告，与Qiming Venture Partners VI, L.P.及Qiming Managing Directors Fund VI, L.P.签订进一步股份转让协议，以1,000万美元收购Valgen Holding Corporation 119,545股B轮优先股，约占其已发行股本的0.79%。交易完成后，瑛泰医疗在Valgen的持股比例将由23.18%提升至23.97%。财务数据显示，Valgen 2025年度收入2.06亿元人民币，净利润4,957.32万元；2024年度收入1.01亿元人民币，净亏损4,035.19万元。瑛泰医疗表示，逐步增持Valgen有助于完善结构性心脏病产品管线，提升在心血管介入领域的整体竞争力。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642266553","title":"瑛泰医疗(01501)：上海证监局已受理公司就建议发行A股进行上市前辅导的备案登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2642266553","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642266553?lang=zh_cn&edition=full","pubTime":"2026-06-12 16:48","pubTimestamp":1781254097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗(01501)发布公告，公司建议于中国证券交易所发行A股。董事会进一步宣布：公司已委任国泰海通证券股份有限公司作为公司建议发行A股有关工作的上市前辅导机构并与其签署辅导协议;及公司已获通知，中国证券监督管理委员会上海监管局已受理公司就建议发行A股进行上市前辅导的备案登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01501","399300","159982","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kdlchina.com","stockEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":0.0489},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.0854},{"period":"1year","weight":0.0203},{"period":"ytd","weight":0.1114}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0345},{"period":"6month","weight":-0.0188},{"period":"1year","weight":-0.0002},{"period":"ytd","weight":-0.0085}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海瑛泰医疗器械股份有限公司（原名：上海康德莱医疗器械股份有限公司）是一家主要从事心内介入器械研发、生产和销售的中国公司。该公司通过两个分部运营其业务。心内介入业务分部主要从事心内介入医疗器械及相关模具、标准件、面罩的销售、制造和研发。其他分部从事其他介入医疗器械的研发，例如神经介入医疗器械、心脏瓣膜植入式医疗器械。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.045707},{"month":2,"riseRate":0.285714,"avgChangeRate":0.009958},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.013734},{"month":4,"riseRate":0.714286,"avgChangeRate":0.03758},{"month":5,"riseRate":0.285714,"avgChangeRate":0.072512},{"month":6,"riseRate":0.428571,"avgChangeRate":0.055661},{"month":7,"riseRate":0.714286,"avgChangeRate":0.022949},{"month":8,"riseRate":0.714286,"avgChangeRate":0.026536},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.070515},{"month":10,"riseRate":0.5,"avgChangeRate":0.064903},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.077012},{"month":12,"riseRate":0.714286,"avgChangeRate":0.030589}],"exchange":"SEHK","name":"瑛泰医疗","nameEN":"INT MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑛泰医疗,01501,瑛泰医疗股票,瑛泰医疗股票老虎,瑛泰医疗股票老虎国际,瑛泰医疗行情,瑛泰医疗股票行情,瑛泰医疗股价,瑛泰医疗股市,瑛泰医疗股票价格,瑛泰医疗股票交易,瑛泰医疗股票购买,瑛泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}